Cadex Genomics

Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response

[Cadex Genomics @CadexGenomics]

At Cadex Genomics, we are interrogating a late-stage cancer patient's blood to determine if a tumor is growing early in a line of therapy and identify non-effective therapy in 12-21 days after starting a cycle of therapy versus waiting 8-12 weeks. https://t.co/RWP4aJe7kX

[AngelMD @angelMD_Inc]

We're excited to have a new channel with which to showcase the entrepreneurs, physicians, dentists, investors & Industry stakeholders advancing healthcare innovation day in and day out.

[Cadex Genomics @CadexGenomics]

Please join Cadex Genomics and AngelMD Capital at a webinar on Wednesday, August 17th to learn more about real-time therapy monitoring for cancer patients. Save your seat: https://t.co/qYps3eI3M4

[Tobin Arthur @tjarthur]

Bill & the Cadex Genomics team are tackling an incredibly important part of the fight against Stage IV cancers.

[Innovation4Alpha @Innovation4A]

New Episode: @CadexGenomics is taking the fight to Stage IV #cancer https://t.co/SRdXOA0Vnn #genomics #diagnostic

[Cadex Genomics @CadexGenomics]

https://t.co/IriBpP8YP6

[AngelMD @angelMD_Inc]

#PitchClub starts at 6PM MT. Hear from @CadexGenomics & @scriptchain1. #startups #physicians #familyoffice #venturecapital #free https://t.co/GqSDpW2jm9

[AngelMD @angelMD_Inc]

Today's #PitchClub revolves around #innovation in #Biotech, #Lab and #Precision medicine. Join us at 6PM MT as we have a discussion with our member startups, #healthcare experts, and innovators. To sign up, click here: https://t.co/dGVBjvpWFA

[AngelMD @angelMD_Inc]

One of our guest speakers on our next #PitchClub is Bill Haack, CEO of Cadex Genomics. Join us with him on April 12 as we discuss more on #Innovation in #Biotech, #Lab and #Precision medicine. Register via this link: https://t.co/dGVBjvpWFA

#AngelMD

[AngelMD @angelMD_Inc]

Our next #PitchClub revolves around #innovation in #Biotech, #Lab and #Precision medicine. Join us on April 12 as we have a discussion with our member startups, #healthcare experts, and innovators. To sign up, click here: https://t.co/dGVBjvI5TI

#AngelMD

[Cadex Genomics @CadexGenomics]

Congratulations to the team @AxoSim.

[AxoSim @AxoSim]

We are excited to announce that we have received the first investment from the new @Benson_CP Fund!

[Cadex Genomics @CadexGenomics]

Cadex Genomics founders Bill Haack and Greg Schafer talk about real-time cancer therapy monitoring on the MedTech Trends podcast.

https://t.co/80VrdfoxVj

[Anne Elise Li @Patent_Lit_Anne]

C&M intellectual property lawyers wrote about the recent Illumina v. Ariosa Diagnostics case in @IAM_Magazine, unpacking the news for diagnostics innovators. Read more: https://t.co/QahcCGsBYj

[Cadex Genomics @CadexGenomics]

Genetic testing for cancer, therapy monitoring, and recurrence - a +$50B addressable market.

https://t.co/8hsvQvqY27

[Cadex Genomics @CadexGenomics]

Happy to have contributed data to this important whitepaper.

[Scott Kopetz @skopetz]

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper | Nature Reviews Clinical Oncology. Notes the opportunities and gaps in knowledge. ⁦@VanMorrisMD⁩ and Arvind Dasari ⁦@MDAndersonNews⁩ https://t.co/0CiyMqmcXU

[Cadex Genomics @CadexGenomics]

"...Diagnostics have been really taken for granted Its been viewed as a commodity for the industry, an afterthought. It isn’t valued properly in the whole healthcare continuum. It isn’t paid for properly. I think that’s changing now..."

https://t.co/yCfORZnday

[Crowell Health Care @CMHealthCareLaw]

The Daily Journal Names C&M Partner Kevin Kroeker “Top Healthcare Lawyer” https://t.co/7OzDIuQUC8

[Cadex Genomics @CadexGenomics]

New blog post: Molecular Diagnostics: A Broken Business Model or Flawed Execution? https://t.co/9gTvoP8lIP #cancer #cancertherapymonitoring #diagnostics

[Jodi Daniel @JodiDaniel]

Flurry of Regulatory Activity Driven by COVID-19 Anxiety Impacts Health Plan Requirements and Permissible Actions - C&M #HealthLaw https://t.co/Y8GaMviacf

[Cadex Genomics @CadexGenomics]

@ideapharma @matthewherper @gbmdna @chris_labarthe Hospital Food-The Eels (David Gray)